We selected SK-OV-3/OVCAR-3/Hey as target cells and CLDN6-CAR1 NK as effector cells, and further verified that upregulation of PD-L1 expression could inhibit the killing sensitivity of CAR-NK cells to tumor cells. Here, CLDN6 is linked to neoplasm.